Research Topic · Peer-Reviewed

Immune Checkpoint Inhibitors

Immune checkpoint inhibitors are a type of molecular drugs that modify the immune system’s ability to fight cancer. They help the immune system recognize cancer cells and attack them more effectively. These drugs can be used to help treat advanced cancers that have proven resistant to other treatments. They provide …

Curated from this journal's research 📚 4 peer-reviewed articles cited Cited 5× across the literature 🗓 Reviewed June 2026

Overview

Immune checkpoint inhibitors are a type of molecular drugs that modify the immune system’s ability to fight cancer. They help the immune system recognize cancer cells and attack them more effectively. These drugs can be used to help treat advanced cancers that have proven resistant to other treatments. They provide hope for patients whose cancer has not responded to other treatments or for whom treatments are not available. Immune checkpoint inhibitors have improved the outlook for many cancer patients, and their use has become more widespread in recent years.

Research published in this journal

4 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 4 articles above have been cited 5 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Immune Checkpoint Inhibitors, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Pancreas.

Journal editorial board
Giuseppe Maulucci · Italy Carlo Molino · United States Cosimo Sperti · Italy

This page summarises published research for orientation; it is not medical or professional advice.